If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
Viking Therapeutics (NASDAQ: VKTX) stock is soaring. Two years ago, the share price hovered just above $2. Today, shares trade around $62. At Friday's prices, a paltry $100 investment in 2022 would have grown to more than $2,700!
Is there still time for you to take advantage? Absolutely.
Viking develops therapies to treat obesity. Two of its drug candidates -- VK2809 and VK2735 -- are currently in phase 2 trials, with promising early results. Patients using VK2735, for example, experienced a mean body weight reduction of up to 15% in just 13 weeks.
Source Fool.com